NANOVIRICIDES, INC. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Nanoviricides, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q2 2024.
  • Nanoviricides, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.39M, a 35% increase year-over-year.
  • Nanoviricides, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$8.52M, a 4.78% increase year-over-year.
  • Nanoviricides, Inc. annual Operating Income (Loss) for 2024 was -$8.52M, a 4.78% increase from 2023.
  • Nanoviricides, Inc. annual Operating Income (Loss) for 2023 was -$8.94M, a 10.2% decline from 2022.
  • Nanoviricides, Inc. annual Operating Income (Loss) for 2022 was -$8.11M, a 7.21% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$8.52M -$2.39M +$1.29M +35% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-27
Q1 2024 -$9.8M -$1.91M -$97.7K -5.39% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$9.7M -$2.18M -$351K -19.1% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 -$9.35M -$2.03M -$409K -25.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$8.94M -$3.68M -$1.88M -105% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-27
Q1 2023 -$7.06M -$1.81M -$22.9K -1.28% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$7.04M -$1.83M +$86.6K +4.51% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 -$7.12M -$1.62M +$990K +37.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$8.11M -$1.79M +$281K +13.6% Apr 1, 2022 Jun 30, 2022 10-K 2023-10-13
Q1 2022 -$8.4M -$1.79M +$320K +15.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$8.71M -$1.92M +$371K +16.2% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 -$9.09M -$2.61M -$342K -15.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$8.74M -$2.07M -$242K -13.2% Apr 1, 2021 Jun 30, 2021 10-K 2022-10-13
Q1 2021 -$8.5M -$2.11M +$435K +17.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$8.94M -$2.29M -$657K -40.2% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 -$8.28M -$2.27M -$283K -14.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$8M -$1.83M +$337K +15.5% Apr 1, 2020 Jun 30, 2020 10-K 2021-10-12
Q1 2020 -$8.33M -$2.54M -$459K -22.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$7.87M -$1.63M +$735K +31% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 -$8.61M -$1.99M +$51.2K +2.51% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$8.66M -$2.17M +$114K +5% Apr 1, 2019 Jun 30, 2019 10-K 2021-10-12
Q1 2019 -$8.77M -$2.08M +$335K +13.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-22
Q4 2018 -$9.11M -$2.37M +$24.6K +1.03% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 -$9.13M -$2.04M +$191K +8.58% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-15
Q2 2018 -$9.33M -$2.28M -$35.7K -1.59% Apr 1, 2018 Jun 30, 2018 10-K 2020-10-13
Q1 2018 -$9.29M -$2.42M +$197K +7.55% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$9.49M -$2.39M -$96.2K -4.19% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$9.39M -$2.23M +$210K +8.61% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$9.6M -$2.25M +$249K +9.98% Apr 1, 2017 Jun 30, 2017 10-K 2019-08-23
Q1 2017 -$9.85M -$2.62M -$567K -27.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$9.28M -$2.3M -$207K -9.92% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-20
Q3 2016 -$9.07M -$2.44M -$215K -9.68% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$8.86M -$2.5M +$53.5K +2.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-10-12
Q1 2016 -$8.91M -$2.05M -$926K -82.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$7.99M -$2.09M -$386K -22.7% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 -$7.6M -$2.23M -$538K -31.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$7.06M -$2.55M +$1.24M +32.8% Apr 1, 2015 Jun 30, 2015 10-K 2017-09-28
Q1 2015 -$8.31M -$1.12M +$111K +8.98% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$8.42M -$1.7M +$47.5K +2.71% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 -$8.47M -$1.69M +$202K +10.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$8.67M -$3.79M -$2.23M -142% Apr 1, 2014 Jun 30, 2014 10-K 2016-09-16
Q1 2014 -$6.44M -$1.23M +$957K +43.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$7.4M -$1.75M -$508K -40.8% Oct 1, 2013 Dec 31, 2013 10-Q/A 2015-02-25
Q3 2013 -$6.89M -$1.89M -$298K -18.7% Jul 1, 2013 Sep 30, 2013 10-Q/A 2015-02-23
Q2 2013 -$6.59M -$1.57M -$37.8K -2.47% Apr 1, 2013 Jun 30, 2013 10-K/A 2013-10-08
Q1 2013 -$6.55M -$2.19M -$114K -5.48% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$6.44M -$1.24M +$93.5K +6.99% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$6.53M -$1.59M -$451K -39.5% Jul 1, 2012 Sep 30, 2012 10-Q/A 2013-11-18
Q2 2012 -$6.08M -$1.53M -$266K -21.1% Apr 1, 2012 Jun 30, 2012 10-K/A 2015-02-23
Q1 2012 -$5.82M -$2.08M +$481K +18.8% Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-05-20
Q4 2011 -$6.3M -$1.34M +$162K +10.8% Oct 1, 2011 Dec 31, 2011 10-Q/A 2013-02-22
Q3 2011 -$6.46M -$1.14M -$29.1K -2.62% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q2 2011 -$6.43M -$1.26M Apr 1, 2011 Jun 30, 2011 10-K/A 2013-10-08
Q1 2011 -$2.56M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q4 2010 -$1.5M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 -$1.11M Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.